These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28052785)

  • 1. Detection, Reporting, and Treatment of Hepatitis C Infections Among Hemodialysis Patients.
    Collier MG; Nguyen DB; Patel PR; Moorman AC
    Infect Control Hosp Epidemiol; 2017 Apr; 38(4):493-494. PubMed ID: 28052785
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current status of the prevalence, diagnosis, and treatment of hepatitis C in patients undergoing hemodialysis].
    Yang GL; Lei XZ
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):233-236. PubMed ID: 28482415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variability of hepatitis C virus in dialysis: the implications.
    Fabrizi F; Lunghi G; Poordad FF; Martin P
    Int J Artif Organs; 2002 Nov; 25(11):1034-48. PubMed ID: 12487391
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C virus infection in end stage renal disease and after kidney transplant.
    Rodriguez-Castro KI; Morisco F; Rigotti P; Rugge M; Burra P
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):340-2. PubMed ID: 25267966
    [No Abstract]   [Full Text] [Related]  

  • 6. [Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification].
    González-Michaca L; Soto-Ramírez LE; Rodríguez R; Gamba G
    Rev Invest Clin; 2001; 53(1):21-7. PubMed ID: 11332047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus infection in maintenance hemodialysis patients: recommendations for diagnostics and treatment.
    Dzekova-Vidimliski P; Sikole A
    Int J Artif Organs; 2017 Feb; 39(12):590-595. PubMed ID: 28165585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus in chronic dialysis patients.
    Natov SN; Pereira BJ
    Minerva Urol Nefrol; 2005 Sep; 57(3):175-97. PubMed ID: 15986016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
    Vallet-Pichard A; Pol S
    Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradicating the Viral Triad in Hemodialysis Units.
    Adams B; Yee J
    Adv Chronic Kidney Dis; 2019 May; 26(3):157-161. PubMed ID: 31202386
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hepatitis C in patients on renal replacement therapy].
    Tornai I; Mátyus J
    Orv Hetil; 2007 Mar; 148(11):489-94. PubMed ID: 17350920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming a treatment barrier in treating hepatitis C in dialysis patients.
    Lapumnuaypol K; Feyssa E
    Semin Dial; 2018 Mar; 31(2):193. PubMed ID: 29405426
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    ; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
    J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology Update for the Treatment of Hepatitis C Virus.
    Hopkins L; Dunlap T; Cline H
    Nurs Clin North Am; 2020 Sep; 55(3):347-359. PubMed ID: 32762855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case report of interferon beta monotherapy for high hepatitis C viral load in dialysis patients.
    Nakajima F; Fukii M; Kitamura T; Sakaida A; Sakaguchi M; Oka H; Morimoto S; Masaki H; Yamahara H; Shibahara N; Inoue T
    Ther Apher Dial; 2007 Aug; 11(4):306-8. PubMed ID: 17661838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
    Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F
    Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of interferon alpha in acute hepatitis C in patients on chronic hemodialysis.
    Süleymanlar I; Sezer T; Işitan F; Yakupoglu G; Süleymanlar G
    Nephron; 1998; 79(3):353-4. PubMed ID: 9678442
    [No Abstract]   [Full Text] [Related]  

  • 20. National surveillance of dialysis associated diseases in the United States, 1993.
    Tokars JI; Alter MJ; Favero MS; Moyer LA; Miller E; Bland LA
    ASAIO J; 1996; 42(3):219-29. PubMed ID: 8725695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.